These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19969069)

  • 1. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products.
    Pashikanti S; de Alba DR; Boissonneault GA; Cervantes-Laurean D
    Free Radic Biol Med; 2010 Mar; 48(5):656-63. PubMed ID: 19969069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo detection of histone H1 modified with advanced glycation end products.
    Pashikanti S; Boissonneault GA; Cervantes-Laurean D
    Free Radic Biol Med; 2011 May; 50(10):1410-6. PubMed ID: 21315148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.
    Cervantes-Laurean D; Schramm DD; Jacobson EL; Halaweish I; Bruckner GG; Boissonneault GA
    J Nutr Biochem; 2006 Aug; 17(8):531-40. PubMed ID: 16443355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.
    Lunceford N; Gugliucci A
    Fitoterapia; 2005 Jul; 76(5):419-27. PubMed ID: 15894431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment.
    Cervantes-Laurean D; Roberts MJ; Jacobson EL; Jacobson MK
    Free Radic Biol Med; 2005 Mar; 38(6):786-95. PubMed ID: 15721989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
    Ahmad MS; Pischetsrieder M; Ahmed N
    Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of advanced glycation end-product formation on eye lens protein by rutin.
    Muthenna P; Akileshwari C; Saraswat M; Bhanuprakash Reddy G
    Br J Nutr; 2012 Apr; 107(7):941-9. PubMed ID: 21864418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein glycation: creation of catalytic sites for free radical generation.
    Yim MB; Yim HS; Lee C; Kang SO; Chock PB
    Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylglyoxal: its presence and potential scavengers.
    Tan D; Wang Y; Lo CY; Ho CT
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():261-4. PubMed ID: 18296351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact glycation end products containing carboxymethyl-lysine and glyoxal lysine dimer obtained from synthetic collagen model peptide.
    Yamada H; Sasaki T; Niwa S; Oishi T; Murata M; Kawakami T; Aimoto S
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5677-80. PubMed ID: 15482946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins.
    Zeng J; Davies MJ
    Chem Res Toxicol; 2005 Aug; 18(8):1232-41. PubMed ID: 16097796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.
    Thornalley PJ; Langborg A; Minhas HS
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):109-16. PubMed ID: 10548540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein and low molecular mass thiols as targets and inhibitors of glycation reactions.
    Zeng J; Davies MJ
    Chem Res Toxicol; 2006 Dec; 19(12):1668-76. PubMed ID: 17173381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed N; Thornalley PJ
    Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging.
    Babizhayev MA; Deyev AI; Savel'yeva EL; Lankin VZ; Yegorov YE
    J Dermatolog Treat; 2012 Oct; 23(5):345-84. PubMed ID: 21756141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the control and inhibition of glycation-the role of the guanidine reaction center with aldehydic and diketonic dicarbonyls. A mass spectrometry study.
    Saraiva MA; Borges CM; Florêncio MH
    J Mass Spectrom; 2006 Oct; 41(10):1346-68. PubMed ID: 17039581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-enzymatic model glycation reactions--a comprehensive study of the reactivity of a modified arginine with aldehydic and diketonic dicarbonyl compounds by electrospray mass spectrometry.
    Saraiva MA; Borges CM; Florêncio MH
    J Mass Spectrom; 2006 Jun; 41(6):755-70. PubMed ID: 16646000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiglycation effect of gliclazide on in vitro AGE formation from glucose and methylglyoxal.
    Li W; Ota K; Nakamura J; Naruse K; Nakashima E; Oiso Y; Hamada Y
    Exp Biol Med (Maywood); 2008 Feb; 233(2):176-9. PubMed ID: 18222972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcarnosine lubricant eyedrops possess all-in-one universal antioxidant protective effects of L-carnosine in aqueous and lipid membrane environments, aldehyde scavenging, and transglycation activities inherent to cataracts: a clinical study of the new vision-saving drug N-acetylcarnosine eyedrop therapy in a database population of over 50,500 patients.
    Babizhayev MA; Micans P; Guiotto A; Kasus-Jacobi A
    Am J Ther; 2009; 16(6):517-33. PubMed ID: 19487926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.